Clinical trial
Evaluation of Cytokines Level as an Indicator of Pulp Inflammation and Its Relation to the Success Rates of Pulpotomy in Primary Molars Affected With Proximal Versus Occlusal Decay: Non-Randomized Clinical Trial
NCT07171229 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Cytokines Level as an Indicator of Pulp Inflammation and Its Relation to the Success Rates of Pulpotomy in Primary Molars Affected With Proximal Versus Occlusal Decay: Non-Randomized Clinical Trial
- Lead sponsor
- Cairo University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 1, 2025
- Completion date
- October 1, 2026
- Enrollment
- 58 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
occlusal caries, proximal caries, pulpitis - reversible